Investment area
Growth Investments
Planetary Health Investments
Region
North America
Date of investment
October 2021
Biomilq is unlocking human potential with breakthrough mammary biotechnology, with a new option for supplemental feeding—one that’s as close to breastmilk as possible and cultivated under safe conditions using their first-of-its-kind technology.
Contact
Kartik Dharmadhikari
Partner
Departments: Growth Investments, Planetary Health Investments
Kartik focuses on investments across industrial biotechnology and is based in our San Francisco office.
Prior to joining Novo Holdings, Kartik served as Associate Partner at McKinsey & Co. working with clients across healthcare, agriculture, chemicals and consumer products on biotechnology strategy and operational topics. Previous to that, Kartik worked at Novozymes in a variety of business building and corporate development roles in both Denmark and the U.S.
Kartik holds an MBA from Columbia Business School and a BA from Northwestern University.logy and is based in our San Francisco office.
Prior to joining Novo Holdings, Kartik served as Associate Partner at McKinsey & Co. working with clients across healthcare, agriculture, chemicals and consumer products on biotechnology strategy and operational topics. Previous to that, Kartik worked at Novozymes in a variety of business building and corporate development roles in both Denmark and the U.S.
Kartik holds an MBA from Columbia Business School and a BA from Northwestern University.
